The blockbuster status of these drugs is protected through a layered defense strategy: Compound Restoration: Leveraging Patent Term Extension (PTE) and PTA to extend core molecule protection as close to the 14-year EPL cap as possible, as seen with semaglutides 2031 extension
Compounding facilities were given until May 2025 to cease manufacturing copies of patent-protected GLP-1 drugs
Fabrini R, De Luca A, Stella L, Mei G, Orioni B, Ciccone S et al
Gerull WD, Puri V, Kozower BD
Fix: Build the protein and training habits now, while the medication is doing part of the work, so the habits are already automatic if the prescription changes
Ghk Cu Copper Peptide has gained a lot of attention in modern times for cellular regeneration support